BSECompany Update12 Sept 2026 · 12 Sept 2026, 04:16 pm

1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director

Sandu Pharmaceuticals Ltd · 524703

✦ AI SummaryMgmt Change

Sandu Pharmaceuticals Ltd has announced the redesignation of Balram Viswanathan as Chairman and Managing Director for 3 years and the appointment of Neeti Kapre as Non-Executive Independent Director for 5 years, both effective from July 11, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

38b38a7b-085a-402b-974f-7b5ca379e15b.pdf

pdf

Download →
View document text
£- SANDU PHARMACEUTICALS LIMITED CIN:L24233GA1985PLC001587 SAMD‘U w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Ref No: Corp.Sec/BSE/2026-27/488 Dated:12.09.2026 Bombay Stock Exchange Ltd, Phirojshah Jeejobhoy Towers, 25" Floor, Dalal Street, Mumbai 400 001 Manager-Department of Corporate affairs Dear Sir, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Members of Sandu Pharmaceuticals Limited, at the 41st Annual General Meeting of the Company held on Friday, September 11, 2026, through Video Conferencing/Other Audio-Visual Means, have approved the following appointments: 1. Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing Director of the Company for the term of 03 years . 2. Appointment of Ms. Neeti Kapre (DIN:06801264) -as Non-Executive Independent Director of the Company for the term of 05 years The aforesaid appointments were approved by the Members by passing the requisite resolutions as set out in the Notice convening the 41st Annual General Meeting. The details of the appointments, as required under Regulation 30 read with Schedule III of the SEBI LODR Regulations, 2015, are enclosed as Annexure A & B Kindly take this intimation in record in compliance with applicable statutory provisions. Kindly take above intimation in your record Thanking You Yours Faithfully, AN ISO 9001:2015 CERTIFIED ORGANISATION <> Cnrporale Office: P. B. No. 17201, Sandu ngdr, D. K. Sandu Marg, Chembur, Mumbai — 400 071 / Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in oN ors! 0 4% __ SANDU PHARMACEUTICALS LIMITED CIN:L24233GA1985PLC001587 SAMD‘U w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407/ 4677154000 , E-mail: sandupharma@sandu.in, Website: www.sandu.in FOR SANDU PHARMACEUTICALS LIMITED PRATIKA MHAMBRAY COMPANY SECRETARY & COMPLIANCE OFFICER A36512 AN I1SO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in - SANDU PHARMACEUTICALS LIMITED SA.:F/DU CIN:L24233GA1985PLC001587 Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Annexure A Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and _Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/1/3762/2026 dated 30th January 2026 Sr No Particulars Details 1 Name of the Director/ Key Shri Balram Viswanathan (DIN: 10245195) Managerial Personnel 2 Reason for change Redesignation from Chairman and Non-Executive Independent Director to Chairman and Managing Director 3 Date of appointment With effect from 11t July 2026 /Cess&a ttierom n—o f appointment Term of appointment: Shri Balram Viswanathan (DIN: 10245195) is appointed as Chairman and Managing Director for the term of 03 years with effect from 11t July 2026 4 Brief Profile Shri. Balram Viswanathan is a B.Com., FCA and CPA (USA) with over 30 years of rich and diverse experience in the financial services industry. An Ex-Banker, his areas of expertise include Audit, Taxation, Mergers & Acqui ns Advisory, Due Diligence, Compliance, Valuation Services, Financial Control, Financial Planning & Analysis, Regulatory Reporting, Business Strategy, Treasury and Risk Management. 5 Disclosure of relationships Shri. Balram Viswanathan is not related to any between directors (in case of Director and/or Key Managerial Personnel appointment of a director) and/or Promoters of the Company. 6 Information as required Shri. Balram Viswanathan Not debarred from Circular No. LIST/COMP/ | holding the office of a director by virtue of any 14/2018- 19 and order passed by SEBI NSE/CML/2018/24 AN ISO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 { Tel.: 9122 2528 4402 / 3306, E-mail: info@sandu.in | SANDU PHARMACEUTICALS LIMITED SA.:F?DU CIN:L24233GA1985PLC001587 Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in ANNEXURE B Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and _Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/1/3762/2026 dated 30th January 2026 Sr Particulars Details 1 Name of the Director/ Dr Neeti Madan Kapre (DIN:06801264) KeyManagerial Personnel 2 Reason for change Appointed as Non-Executive Independent Director 3 Date of appointment With effect from 11t July 2026 |/ Cessat& iteormn o f appointment Term of appointment: - Appointment of Dr Neeti Madan Kapre (DIN:06801264) as Non-Executive Independent Director for a term of five (5) years effective 11t July 2026 ,not liable to retire by rotation. 4 Brief Profile Dr Neeti Madan Kapre has done e MBBS- Gold Medallist (First class with Distinction all 4 years)- Indira Gandhi Government Medical College, Nagpur e M.S (ENT) — K.E.M. Hospital, Mumbai e D.N.B(ENT) e Clinical Research Fellow, Head and Neck Services, TMH, Mumbai (August 2013 to August 2015) e Global Fellowship Programme, International Foundation Head and Neck Oncologic Societies e Observer ship under the Global Fellowship Programme at Memorial Sloan Kettering Cancer Centre, New York Memberships e Founder Member — (a)Indian Society of Thyroid Surgeons (b)Vidarbha Society of Head and Neck Oncology * Executive committee member- AN ISO 9001:2015 CERTIFIED ORGANISATION <> Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai ~ 400 071 7 91 22 2528 4402 / 3306, E-mail: info@sandu.in H Tel.: 4% __ SANDU PHARMACEUTICALS LIMITED CIN:L24233GA1985PLC001587 SAMDU w Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Indian Society of Thyroid Surgeons Thyroid Society Nagpur e Life Member - Asia Pacific Thyroid Society - Foundation of Head & Neck Oncology - Association of Otolaryngologist in India - Vidarbha Society of Head & Neck Oncology - Indian Society of Otolaryngologist. 5 Disclosure of Dr Neeti Madan Kapre is not related to any Director relationships between and/or Key Managerial Personnel and/or Promoters of directors (in case of the Company. appointment of a director) 6 Information as required Dr Neeti Madan Kapre Not debarred from holding the Circular No. LIST/COMP/ office of a director by virtue of any order passed by 14/2018- 19 and SEBI NSE/CML/2018/24 FOR SANDU PHARMACEUTICALS LIMITED PRATIKA MHAMBRAY COMPANY SECRETARY & COMPLIANCE OFFICER A36512 AN ISO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071 91 22 2528 4402 / 3306, E-mail: info@sandu.in